Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] — Common Side Effects

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
Side Effect Total Reports Drugs Deaths Hosp. Life-Threat.
Bone density decreased 10,668 4 159 632 0
Renal injury 9,323 4 168 505 3
Skeletal injury 8,320 1 172 490 0
Chronic kidney disease 7,441 6 221 933 4
Osteonecrosis 7,302 6 107 466 0
Bone loss 7,046 2 107 382 0
Multiple fractures 6,818 2 109 421 0
Renal failure 6,796 6 395 1,041 29
Foetal exposure during pregnancy 5,798 6 792 722 71
Osteoporosis 5,567 6 89 455 2
Tooth loss 4,483 1 57 266 0
Virologic failure 4,390 6 160 262 24
Drug resistance 3,890 6 145 409 14
Pathogen resistance 3,661 6 55 185 10
Pain 3,477 6 273 511 10
Viral mutation identified 3,445 6 38 97 0
Emotional distress 2,849 2 71 375 0
Anxiety 2,831 6 80 565 4
Exposure during pregnancy 2,474 6 261 294 33
Anhedonia 2,449 2 57 331 0
Drug ineffective 2,377 6 438 338 36
Renal impairment 2,299 6 73 424 22
Osteopenia 2,298 5 17 195 0
Treatment failure 2,284 6 289 83 9
Tooth injury 2,013 2 21 84 0
Blood creatinine increased 1,793 6 49 278 17
Maternal exposure during pregnancy 1,788 6 116 309 24
Death 1,736 6 1,731 153 68
Immune reconstitution inflammatory syndrome 1,709 6 265 803 76
Acute kidney injury 1,620 6 123 777 72
← Back to Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] Compare drugs in this class →